New data from our study on liver toxicity of cyclin-dependent kinase inhibitors for advanced breast cancer on show now at #ILC2022 here in London. #DILI was an issue in 14% of cases 👉 #NAFLD at baseline strong association RR 13.3 @MScaravaglio@HSG_Gastro#LiverTwitter